Long-term remission in a patient with refractory thrombotic thrombocytopenic purpura treated with rituximab and plasma exchange.
Basquiera
A L
AL
Damonte
J C
JC
Abichaín
P
P
Sturich
A G
AG
García
J J
JJ
D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D058846:Antibodies, Monoclonal, Murine-Derived; D003131:Combined Modality Therapy; D006801:Humans; D007155:Immunologic Factors / Q000627:therapeutic use; D010951:Plasma Exchange; D010976:Platelet Count; D011693:Purpura / Q000188:drug therapy* / Q000628:therapy*; D011697:Purpura, Thrombotic Thrombocytopenic / Q000188:drug therapy* / Q000628:therapy*; D000069283:Rituximab
D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D007155:Immunologic Factors; D000069283:Rituximab